All sequencing data are available from the European Nucleotide Archive (accession number ERP113121). Processed count data are available within the manuscript and its Supporting Information files.

Introduction {#sec001}
============

The blood fluke *Schistosoma mansoni* is a major aetiological agent of hepatic and intestinal schistosomiasis, a Neglected Tropical Disease that affects over 200 million people around the world, largely in developing regions \[[@pntd.0007743.ref001]\]. Standard treatment of schistosomiasis relies on a single drug, praziquantel, and drug resistance is an ever-present threat with emerging reports of reduced efficacy to praziquantel in the field \[[@pntd.0007743.ref002]\]. A better understanding of the molecular and cellular mechanisms underlying the establishment of infections could reveal potential vulnerabilities for targeting in new control tools.

Susceptible aquatic snails transmit schistosomes between mammalian hosts by releasing infectious larvae called cercariae that seek out a mammalian host, penetrate through its skin and transform into a juvenile form known as schistosomula. The schistosomula enter the bloodstream and by day 6 post-infection are mainly present in the lung capillaries \[[@pntd.0007743.ref003],[@pntd.0007743.ref004]\]. The parasites subsequently circulate within blood vessels throughout the body while developing organs, growing in size and eventually reaching the liver. In the case of *S*. *mansoni*, male and female parasites pair up after approximately 28 days post-infection and migrate from the liver to the mesenteric veins \[[@pntd.0007743.ref003]\]. By day-35 the parasites reach full maturity in the mesenteric veins \[[@pntd.0007743.ref003]\], where they release eggs that traverse the intestinal wall, reach the gut lumen, and pass with faeces into the environment.

Large-scale transcriptional changes have been extensively described across the life-cycle of *Schistosoma* spp. but in many cases ESTs, SAGE or microarray approaches were used \[[@pntd.0007743.ref005]--[@pntd.0007743.ref012]\] that lack the dynamic range and sensitivity of more contemporary RNA-seq approaches. Where RNA-seq has been used, the focus has been on just a few developmental stages. Examples include a focus on eggs, the drivers of schistosome-induced pathology, and the transformation of the free-living cercariae into schistosomula, where extraordinary morphological and physiological changes mark the start of intra-mammalian development \[[@pntd.0007743.ref013],[@pntd.0007743.ref014]\]. These and other studies have produced new lists of abundantly transcribed factors including numerous G-protein coupled receptors (GPCRs) \[[@pntd.0007743.ref015]\], as well as confirming previous biochemical observations, such as the switch to anaerobic metabolism as the parasite's physiological environment changes \[[@pntd.0007743.ref016],[@pntd.0007743.ref017]\]. Studies in both *S*. *mansoni* and *S*. *japonicum* have shown high expression of genes involved in nutrient acquisition and oxidative stress responses in adult worms \[[@pntd.0007743.ref008],[@pntd.0007743.ref009],[@pntd.0007743.ref011]\]. Prominent components and processes of reproductive development and egg production have also been discovered but in many cases the primary motivation has been to identify tentative drug and vaccine targets, such as tetraspanins and GPCRs \[[@pntd.0007743.ref010]\]. Specific comparisons of males and females from single-sex and mixed-sex infections have provided more insight into reproductive development and male-female interactions, including the prominent roles of neuropeptide signalling and stem cell differentiation \[[@pntd.0007743.ref018]\].

In contrast to adult stages, gene expression in early stages of intra-mammalian development has been poorly studied. Studying several specific developmental stages has been compromised by difficulties in obtaining parasite material. This has resulted in a complex picture being pieced together using material obtained *in vivo* and *in vitro* \[[@pntd.0007743.ref010],[@pntd.0007743.ref017]\]. Given the enormous differences between the *in vivo* and *in vitro* environment, gene expression is likely to be dramatically affected, particularly amongst those genes related to nutrient acquisition, stress responses and immune evasion \[[@pntd.0007743.ref008]\]. The lung stage, in particular, is a key point of attrition during primary and challenge infections of animal models \[[@pntd.0007743.ref004],[@pntd.0007743.ref019],[@pntd.0007743.ref020]\].

In order to fill these knowledge gaps, we have analysed the *S*. *mansoni* transcriptome during six discrete stages of development within experimentally-infected mice, ranging from the early lung stage to sexually mature egg-laying worms. Gene expression changes correlated well with the well-described biology of egg production in the adult stages, and with growth and developmental control in the liver developmental stages of the parasite. Notably, host immune-evasion and oxidative stress regulation by the parasite, were clearly evident in the lung-stage transcriptome in addition to potential novel players in host-parasite interactions. This study not only provides a rich and systematic resource for the community to understand schistosome biology, but also reveals new molecular mediators at the host-parasite interface.

Materials and methods {#sec002}
=====================

Ethical statement {#sec003}
-----------------

All procedures involving mice were performed by authorised personnel according to the UK Animals (Scientific Procedures) Act 1986 with project license held by MJD (number PPL 40/3595). The work was approved by the Ethical Review Committee of the University of Nottingham and was carried out in strict accordance with UK Home Office regulations for animal welfare and amelioration of suffering.

Mouse infection {#sec004}
---------------

Mice were infected with cercariae of *S*. *mansoni* (Puerto Rican strains) shed from *Biomphalaria glabrata* snails as described \[[@pntd.0007743.ref021]\]. In brief, percutaneous infections were performed by applying suspensions of mixed-sex cercariae to the shaved abdomens of anaesthetised mice and leaving for 30 minutes. Mice were infected with the following numbers of cercariae: 2000 to provide day-6 and day-13 parasites, 500 for days 17 and 21, 350 for day 28, and 300 for day 35 ([Fig 1](#pntd.0007743.g001){ref-type="fig"}). Four mice were used for adult stage parasites and up to eight mice were used for juvenile stages ([Fig 1](#pntd.0007743.g001){ref-type="fig"}). More mice were used for early time points due to the greater uncertainty in acquiring the samples. All mice were females of CD-1 outbred strain (Charles River, Harlow, UK) aged between 8--12 weeks by the time of infection. A pool of mixed-sex parasites from each mouse was considered a biological replicate.

![The numbers of mice and cercariae used for infections.\
Mice were infected with indicated numbers of cercariae for parasite collection at six time points post-infection. The number of mice used for each time point is shown on the left. The method for parasite collection at day 6 involves mincing and incubation of the lung. Collections at other time points were done by portal perfusion.](pntd.0007743.g001){#pntd.0007743.g001}

Parasite material collection and imaging {#sec005}
----------------------------------------

On the indicated day post-infection, mice were culled using an overdose of pentobarbitone containing 10 U/ml heparin. Day-6 lung-stage parasites were collected as described \[[@pntd.0007743.ref021]\]. Briefly, lungs collected from infected mice were minced using a sterile scalpel cut into approximately 1 mm^3^ pieces and incubated in 50 ml heparinised modified Basch media (10 U/ml heparin, 1 mg/ml Lactalbumin hydrolysate powder, 0.5 μM Hypoxanthine, 0.008 mg/ml Insulin, 1 μM Hydrocortisone, 0.2 μM Triiodothyronine, 0.5X MEM Vitamins, 5% Schneiders Drosophila Medium, 1% Hepes Buffer, 10% Fetal bovine serum, 2% Antibiotic-Antimycotic in DMEM) for approximately 1 hour at room temperature, followed by 3 hours at 37°C, 5% CO~2~ to allow the parasites to exit the tissue. The tube contents were mixed by turning the tube 2--3 times before being passed through a 600 μm mesh into new 50 ml tubes to separate large pieces of tissue from worms. The filtrate was centrifuged at 150 x g for 3 minutes at room temperature and approximately half of the supernatant was discarded by gently decanting. Lung-stage worms were recovered using a Pasteur pipette to collect approximately 1--1.5 ml from the bottom of the tube. Given that parasites from day-6 post-infection were collected only from the lung and not by perfusion, circulating parasites that had left the lung were therefore excluded. For this reason, day-6 worms in the present study are hereafter referred to as 'lung stage'.

For all other time points, parasites were collected by portal perfusion with approximately 30 ml of perfusion media (Dulbecco\'s Modified Eagle\'s Medium (DMEM) high glucose, with 10 U/ml heparin). Parasites were left to settle for 30 minutes at room temperature and washed twice with DMEM before being recovered with a Pasteur pipette from the bottom of the tube.

Parasites were transferred to a Petri dish for imaging using an Olympus SZ61dissecting microscope with a Euromex Cmex10 camera and Image Focus 4.0 software. A subset of the parasites from each mouse was imaged for morphology scoring. After imaging, parasites were transferred into a 2 ml Eppendorf tube and centrifuged at 150 x g for 3 minutes before replacing the supernatant with 1 ml TRIzol (Thermo Fisher), left at room temperature for up to 1 hour, transferred to dry ice for transport, and later stored at -80 ºC until RNA extraction. An average of 31 worms were imaged per mouse (range 18--75 worms); this did not represent a total number of parasites collected.

Parasite morphology scoring {#sec006}
---------------------------

Parasite morphology was classified using numerical scores based on published categories \[[@pntd.0007743.ref022]\]. Parasite features used for categorisation were the presence of a haemozoin-filled gut, the shape and length of the gut (fork end, closed end, proportion of the posterior end of the gut to the anterior section), and whether the worms were paired or unpaired. The scoring was performed blindly, i.e. all images were renamed to randomised numbers. Different numbers of worms ranging from 18--75 were morphologically scored among replicates; hence, the number of parasites that fell into each morphology category was shown as a percentage of the total worms morphologically scored in that replicate.

RNA extraction {#sec007}
--------------

RNA was extracted from parasite material using a modified phenol-chloroform method and column purification. Briefly, frozen samples in TRIzol reagent were thawed on ice, resuspended by gently pipetting and transferred to 2 ml tubes containing ceramic beads (MagNA Lyser Green Beads, Roche). The parasites were homogenised in a MagNA Lyser Instrument (FastPrep-24) at maximum speed twice for 20 seconds, with a 1-minute rest on ice in between. Next, 200 μl of chloroform-isoamyl alcohol 24:1 was added to each tube, followed by vigorous shaking for 5 seconds. The tubes were centrifuged at 13,000 x g for 15 minutes at 4°C to separate the aqueous and organic solvent layers. The aqueous layer was transferred into a RNase-free 1.5 ml tube and one volume of 100% ethanol added and mixed by pipetting. The mixture was transferred to Zymo RNA Clean & Concentrator-5 column (Zymo Research) and processed according to the manufacturer\'s protocol. To elute the RNA, 15 μl of RNase-free water was added to the column and centrifuged for 30 seconds at 13,000 x g. The RNA concentration and integrity were measured by Agilent RNA 6000 Nano kit (Agilent Technologies), and its purity assessed using a NanoDrop spectrophotometer.

Library preparation and sequencing {#sec008}
----------------------------------

One to 2.8 μg of RNA was used to prepare each sequencing library. The libraries were produced using TruSeq Stranded RNA Sample Preparation v2 Kits (Illumina). Libraries were amplified using 10--14 cycles of PCR and cleaned using Agencourt AMPure XP Beads (Beckman Coulter). The libraries were quantified by qPCR before sequencing using the Illumina HiSeq 2500 platform. All sequencing data were produced as 75 bp paired-end reads and are available through ENA study accession number ERP113121.

Read mapping and quantifying read counts {#sec009}
----------------------------------------

Sequencing reads ([S1 File](#pntd.0007743.s022){ref-type="supplementary-material"}) were mapped to the *S*. *mansoni* reference genome v5 \[[@pntd.0007743.ref017]\] from WormBase ParaSite \[[@pntd.0007743.ref023]\] using TopHat version 2.0.8 \[[@pntd.0007743.ref024]\] with default parameters except the following: -g 1 (only report 1 alignment for each read); \-- library-type fr-firststrand (for dUTP Illumina library); -a 6 (minimum anchor length); -i 10 and \-- min-segment-intron 10 (minimum intron length); -I 40000 and \-- max-segment-intron 40000 (maximum intron length); \-- microexon-search (find alignment to micro-exons). The resulting BAM files of accepted hits were sorted by read name (-n option) and indexed using SAMtools \[[@pntd.0007743.ref025]\]. A GFF file of gene annotations from [GeneDB.org](http://GeneDB.org) was filtered to keep only the longest transcript for each gene ([S2 File](#pntd.0007743.s023){ref-type="supplementary-material"}). The GFF file and sorted BAM files were used as inputs for HTSeq-count version 0.7.1 \[[@pntd.0007743.ref026]\] to obtain read counts per transcript and used for read count analysis ([S3 File](#pntd.0007743.s024){ref-type="supplementary-material"}). HTSeq-count was run with default parameters except with strand option set to suit dUTP libraries (-s reverse), and alignment score cut-off increased (-a 30).

Differential expression analysis {#sec010}
--------------------------------

Analyses were performed using RStudio version 0.99.489 \[[@pntd.0007743.ref027]\], with R version 3.3.1 \[[@pntd.0007743.ref028]\]. DESeq2 (version 1.12.3) \[[@pntd.0007743.ref029]\] was used to import read counts, to investigate overall transcriptomic differences among samples using principal component analysis (PCA), to normalise read counts, and to identify genes differentially expressed in the time-course or in pairwise comparisons. PCA used regularized log--transformed (rlog-transformed) read count data as input. Differential expression analyses were performed with either likelihood-ratio tests (when the whole time-course was considered) or with the Wald test (when used with pairwise comparisons) and statistical significance was determined by adjusting p-values according to the Benjamini--Hochberg procedure to control false discovery rate \[[@pntd.0007743.ref030]\]. Differentially expressed genes were defined as those with adjusted p-value \< 0.01 and log~2~ fold change in expression \> 1 or \< -1.

Gene clustering {#sec011}
---------------

Genes were clustered using self-organising maps constructed in the R package Kohonen (version 2.0.19) \[[@pntd.0007743.ref031]\] based on their mean-normalised, rlog-transformed counts over the time-course. The mean-normalised counts were used to calculate means of replicates at each time point for each gene and used as input for clustering. Genes were grouped based on their expression pattern into 96 clusters. To reduce background signal, only genes that were differentially expressed in at least one time point (likelihood ratio test, adjusted p-value \< 0.01, 7987 genes, [S1 Table](#pntd.0007743.s008){ref-type="supplementary-material"}) were used as inputs for clustering.

Gene Ontology enrichment {#sec012}
------------------------

Gene Ontology (GO) annotations for the *S*. *mansoni* genes were downloaded from [GeneDB.org](http://GeneDB.org). Identification of enriched GO terms (biological process terms) was performed using topGO (version 2.24.0) \[[@pntd.0007743.ref032]\] with a *weight* algorithm and Fisher's exact test. All *S*. *mansoni* genes were used as a reference background for the enrichment analysis.

Protein structure prediction {#sec013}
----------------------------

Amino acid sequences for proteins of interest were obtained from [GeneDB.org](http://GeneDB.org). Protein 3D structures were predicted from amino acid sequences using I-TASSER online server (v5.0) \[[@pntd.0007743.ref033]--[@pntd.0007743.ref035]\] with default parameters. TM-scores indicate similarity between two structures. The value ranges between 0--1, with a value of one indicating a perfect match. Images of the predicted structures and their alignment were from.pdb files obtained from I-TASSER predictions or from Protein Data Bank (PDB) \[[@pntd.0007743.ref036]\] and reproduced using Chimera software \[[@pntd.0007743.ref037]\].

Protein domain searching {#sec014}
------------------------

Protein domains were identified from amino acid sequences using InterProScan online server (v60, v61 and v78) \[[@pntd.0007743.ref038]\]. CathDB \[[@pntd.0007743.ref039]\] was used to explore protein structural domains and to search by structural match.

Results {#sec015}
=======

Parasite morphologies correlate with marked transcriptional signatures in developing parasites {#sec016}
----------------------------------------------------------------------------------------------

Changes in the morphology and transcriptome during intra-mammalian development of *S*. *mansoni* were investigated in parasites collected from experimentally-infected mice at time points between 6--35 days post-infection ([Fig 1](#pntd.0007743.g001){ref-type="fig"}).

Lung schistosomula were morphologically homogeneous, whereas circulating larvae that had left the lungs (days 13 to 28) were heterogeneous in size and developmental progression ([Fig 2](#pntd.0007743.g002){ref-type="fig"}), consistent with previous reports \[[@pntd.0007743.ref003],[@pntd.0007743.ref022]\]. At 28 days post infection, most of the parasites had developed into adults and worm pairs started to become evident. All day-35 parasites were fully mature paired male and female adults ([Fig 2](#pntd.0007743.g002){ref-type="fig"}).

![Morphology of *in vivo S*. *mansoni*.\
A) Morphological scoring of *S*. *mansoni* parasites collected at the indicated time points post-infection (D06 to D35). Heatmap columns represent the twenty-one distinct morphological groups following published scores \[[@pntd.0007743.ref022]\], and heatmap rows indicate biological replicates of the infections, i.e. parasites collected from individual mice. Colours on the heatmap show the number of worms that fell into each morphological group, normalised as a percentage of the total number of worms that were scored within the replicate. B) Representative images of worms from each time point. Scale bars: 1 mm.](pntd.0007743.g002){#pntd.0007743.g002}

Parasites from individual mice were pooled and each of these pools was considered a biological replicate. At least 3 biological replicates were obtained for each time point and changes in their transcriptomes were measured using RNA-seq. A principle components analysis showed tight clustering of biological replicates and a large variation among the time points ([Fig 3](#pntd.0007743.g003){ref-type="fig"}). All replicates from lung schistosomula clustered separately from day-13 to day-21 groups, and the adult stages (days 28 and 35) clustered away from the other time points, indicating a good correlation between the morphological progress and marked transcriptional signatures of the developing parasite. The transcriptional differences observed between day-28 and day-35 parasites may be related to sexual maturation and egg laying, which is onset at day 35 \[[@pntd.0007743.ref022]\]. In contrast, the transcriptional similarity of parasites at days 13, 17, and 21 may reflect genuinely similar gene expression profiles or the heterogeneity in the overlapping morphologies of parasites at those three time points.

![Principal component analysis of the transcriptomic data from all time points.\
PCA plot of all transcriptomic data based on rlog-transformed normalised read counts. Each dot represents the transcriptome from a pool of parasites collected from an individual mouse, i.e. one biological replicate.](pntd.0007743.g003){#pntd.0007743.g003}

Gene expression changes associated to developmental milestones of *S*. *mansoni* {#sec017}
--------------------------------------------------------------------------------

Comparing the transcriptomes of parasites collected 6- and 13-days post-infection provided information on the transition between lung schistosomula and circulating juveniles, i.e. parasites that have already left the lungs and have entered the systemic circulation *via* the pulmonary veins. In the lung schistosomula, 864 genes were up-regulated compared with day 13 juveniles ([S2 Table](#pntd.0007743.s009){ref-type="supplementary-material"}). The up-regulated genes related to multiple signalling processes including signal transduction and neuronal signalling pathways ([S3 Table](#pntd.0007743.s010){ref-type="supplementary-material"}). This suggests that neuronal activities were increased in the lung stage, compared with day-13 stage, perhaps for sensing and locomotion to allow parasite migration through the lung capillary bed, to reach the pulmonary veins and continue through the rest of bloodstream circulation \[[@pntd.0007743.ref040]\]. In contrast, 686 genes were up-regulated in the day-13 schistosomula ([S2 Table](#pntd.0007743.s009){ref-type="supplementary-material"}), including genes involved in mitosis and its associated processes, such as translation, post-translational modification, and transcriptional regulation ([S3 Table](#pntd.0007743.s010){ref-type="supplementary-material"}). This is consistent with the growth phase described in day-13 worms and corroborates reports that mitosis is not detectable in the lung stage \[[@pntd.0007743.ref003],[@pntd.0007743.ref041]\].

As the parasites develop from circulating juveniles to adult forms, up-regulated genes identified in the liver stage (day 21) compared to pre-egg-laying adult stage (day 28) were involved in cell division, differentiation, and developmental regulation ([S4](#pntd.0007743.s011){ref-type="supplementary-material"} and [S5](#pntd.0007743.s012){ref-type="supplementary-material"} Tables). In contrast, gene expression in the day-28 worms showed a massive up-regulation of genes involved in egg production such as *tyrosinase* (Smp_050270, Smp_013540), *eggshell protein* (Smp_000430), and *Trematode Eggshell Synthesis domain containing protein* (Smp_077890) ([S4 Table](#pntd.0007743.s011){ref-type="supplementary-material"}). The Gene Ontology (GO) terms *metabolic processes* and *biosynthesis processes* were enriched in up-regulated genes at day 28 ([S5 Table](#pntd.0007743.s012){ref-type="supplementary-material"}), possibly also reflecting synthesis of compounds necessary for egg production (*tyrosinase* genes are annotated with the terms *organic hydroxy compound biosynthetic process*). However, the increased biosynthesis also likely reflected increased nutrient and energy requirements, and scavenging of host-derived substrates by the parasites because GO terms for lipid metabolic process, glycerol metabolic process, purine ribonucleoside salvage, and carbohydrate transport were also enriched ([S5 Table](#pntd.0007743.s012){ref-type="supplementary-material"}). The genes contributing to the enriched GO term carbohydrate transport encode two confirmed glucose transporters (Smp_012440, Smp_105410) \[[@pntd.0007743.ref042]\] and a third, non-confirmed, putative glucose transporter (Smp_139150).

Between days 28 and 35, the parasites become fully established in the portal system within the mesentery veins and lay large numbers of eggs. Expectedly, amongst the 72 genes that were up-regulated during the progression from day 28 to day 35, many were related to egg production ([S6 Table](#pntd.0007743.s013){ref-type="supplementary-material"}). Proteases involved in blood feeding \[[@pntd.0007743.ref043]\], *cathepsin B*, *D*, and *L* were also up-regulated (approximately 2.5-fold; [S6 Table](#pntd.0007743.s013){ref-type="supplementary-material"}), consistent with the high nutrient requirement of egg-producing females. In addition, down regulation of genes involved in signalling and developmental control was evident ([S6](#pntd.0007743.s013){ref-type="supplementary-material"} and [S7](#pntd.0007743.s014){ref-type="supplementary-material"} Tables).

To further explore transcriptomic changes across all developmental stages analysed, genes were clustered into 96 groups based on their expression profile over the whole time-course ([Fig 4](#pntd.0007743.g004){ref-type="fig"} and [S1 Fig](#pntd.0007743.s001){ref-type="supplementary-material"}). Specific expression patterns became evident for multiple clusters; for instance, clusters 1, 2, 9, 10, 17, 25, 26, 27, 33, and 34 showed increased expression in the developing parasites, from day 13 to day 28 post-infection ([Fig 4](#pntd.0007743.g004){ref-type="fig"} orange boxes and [S1 Fig](#pntd.0007743.s001){ref-type="supplementary-material"}). These clusters comprised a total of 737 genes with the top five enriched GO terms related to cell replication and regulation ([S8](#pntd.0007743.s015){ref-type="supplementary-material"} and [S9](#pntd.0007743.s016){ref-type="supplementary-material"} Tables). Striking up-regulation in adult stages (day 28 and day 35) was seen in six clusters, particularly cluster 96 and, to a lesser extent, clusters 79, 80, 87, 88 and 95 ([Fig 4](#pntd.0007743.g004){ref-type="fig"} pink boxes, [S1 Fig](#pntd.0007743.s001){ref-type="supplementary-material"} and [S8 Table](#pntd.0007743.s015){ref-type="supplementary-material"}). These clusters comprised genes involved in egg production, such as two tyrosinase genes (Smp_013540 and Smp_050270) involved in protein cross-linking during egg-shell synthesis \[[@pntd.0007743.ref044]\]. Two of the egg-shell precursors (Smp_131110 and Smp_014610) \[[@pntd.0007743.ref045]\] were also present in cluster 96 ([S8 Table](#pntd.0007743.s015){ref-type="supplementary-material"}). In addition, multiple genes of unknown function shared expression patterns with these genes related to egg-production, suggesting that they may have a related function or share the same pathway(s) ([S8 Table](#pntd.0007743.s015){ref-type="supplementary-material"}).

![Clusters of genes based on time-course expression pattern.\
Expression profiles of genes showing differential expression in at least one time point, clustered into 96 groups. The clustering was based on mean-normalised rlog-transformed raw read counts over six time points. The y-axes are scaled independently to emphasise the differences between clusters. Plots with a single y-axis scale are shown in [S1 Fig](#pntd.0007743.s001){ref-type="supplementary-material"}. The coloured boxes mark clusters that were part of the GO term enrichment analyses or were discussed in detail; orange, clusters of genes with increased expression during the liver stage; blue, high expression in the lung stage and steadily declined toward adult stages; yellow, high expression in the lung stage; green, high expression in the lung and adult stages with low expression during liver stages; pink, high expression in adult stages.](pntd.0007743.g004){#pntd.0007743.g004}

Signalling pathways, iron homeostasis and micro-exon genes (MEGs) in lung schistosomula {#sec018}
---------------------------------------------------------------------------------------

Given the scarcity of data on lung schistosomula, we investigated gene expression at this stage by performing pairwise comparisons between the lung stage and day-13 parasites, and by focusing on data that was clustered over multiple time points but showed striking differences in the lung. High expression in the lung stage, compared with other intra-mammalian stages, was seen mainly in three clusters (8, 24 and 32), where high expression on day 6 precipitously dropped to a low baseline for the rest of the time-course ([Fig 4](#pntd.0007743.g004){ref-type="fig"} yellow boxes, [S1 Fig](#pntd.0007743.s001){ref-type="supplementary-material"} and [S8 Table](#pntd.0007743.s015){ref-type="supplementary-material"}). The three clusters contained a total of 72 genes, and a GO term enrichment analysis suggested that many of these were involved in signalling, metabolism, transport and iron homeostasis ([S10 Table](#pntd.0007743.s017){ref-type="supplementary-material"}).

Genes related to developmental control were also over-represented in 11 clusters that showed high expression in lung stage followed by a steady decline towards adult (cluster 5, 6, 7, 13, 14, 15, 16, 21, 22, 23, 31; [Fig 4](#pntd.0007743.g004){ref-type="fig"} blue boxes, [S1 Fig](#pntd.0007743.s001){ref-type="supplementary-material"} and [S11 Table](#pntd.0007743.s018){ref-type="supplementary-material"}), including several transcription factors and cell adhesion proteins involved in embryogenesis and neuronal development, such as *SOX* (Smp_148110, Smp_161600) and *procadherin family* (such as Smp_011430, Smp_141740, and Smp_155600) \[[@pntd.0007743.ref046],[@pntd.0007743.ref047]\]. In addition, *Wnt*, *nanos*, and *frizzled receptors*, important for cell-fate determination and control of development \[[@pntd.0007743.ref048]--[@pntd.0007743.ref050]\], showed a similar expression pattern.

Compared to day-13 parasites, the relative expression of multiple genes related to signalling processes was high in the lung stage; amongst 864 highly expressed genes, the top-four enriched GO terms were *signal transduction*, *male sex determination*, *potassium ion transport*, and *neurotransmitter transport* ([S2](#pntd.0007743.s009){ref-type="supplementary-material"} and [S3](#pntd.0007743.s010){ref-type="supplementary-material"} Tables). The enrichment of several other GO terms, albeit with weaker statistical support (p-values: 0.036--0.045), provided further evidence for the prominent role of signalling processes in the lung stage ([S2](#pntd.0007743.s009){ref-type="supplementary-material"} and [S3](#pntd.0007743.s010){ref-type="supplementary-material"} Tables). Several developmental terms were also enriched (e.g. *cell differentiation*, *homophilic cell adhesion*, *brain development*, *male sex determination*). The pronounced expression of genes involved in neuronal signalling--inferred from the GO terms *neuropeptide signalling pathway*, *sodium ion transport*, *chloride transport* and *neurotransmitter transport* ([S2](#pntd.0007743.s009){ref-type="supplementary-material"} and [S3](#pntd.0007743.s010){ref-type="supplementary-material"} Tables)--may reflect the parasite's responsiveness to environmental cues. Consistent with the broad picture provided by GO term enrichment, the top up-regulated genes in the lung stage included a *rhodopsin orphan GPCR* (Smp_203400), and two Ras related proteins (Smp_132500, Smp_125060), all of which were up-regulated more than 32-fold ([Table 1](#pntd.0007743.t001){ref-type="table"}).

10.1371/journal.pntd.0007743.t001

###### Top 20 genes up-regulated in lung stage compared to day-13 schistosomula.

![](pntd.0007743.t001){#pntd.0007743.t001g}

  Gene identifier   [\*](#t001fn001){ref-type="table-fn"}Log~2~FC (lung/D13)   Adjusted p-value   Product name
  ----------------- ---------------------------------------------------------- ------------------ ----------------------------------------------
  Smp_138080        12.62                                                      1.48E-19           MEG-3 (Grail) family
  Smp_138070        11.99                                                      3.58E-30           MEG-3 (Grail) family
  Smp_159810        11.22                                                      1.02E-48           MEG-2 (ESP15) family
  Smp_159800        9.66                                                       5.10E-28           MEG-2 (ESP15) family
  Smp_181510        9.58                                                       1.15E-13           hypothetical protein
  Smp_032990        8.98                                                       7.14E-13           Calmodulin 4 (Calcium binding protein Dd112)
  Smp_159830        8.69                                                       1.00E-05           MEG-2 (ESP15) family
  Smp_138060        8.06                                                       3.76E-09           MEG-3 (Grail) family
  Smp_203400        7.34                                                       1.88E-07           rhodopsin orphan GPCR
  Smp_005470        7.31                                                       3.34E-08           dynein light chain
  Smp_077610        6.61                                                       6.19E-07           hypothetical protein
  Smp_166350        6.59                                                       1.31E-06           hypothetical protein
  Smp_180330        5.97                                                       2.91E-32           MEG 2 (ESP15) family
  Smp_205660        5.84                                                       4.52E-15           hypothetical protein
  Smp_033250        5.80                                                       4.43E-05           hypothetical protein
  Smp_132500        5.73                                                       4.50E-04           ras and EF hand domain containing protein
  Smp_152730        5.68                                                       3.41E-11           histone lysine N methyltransferase MLL3
  Smp_241430        5.61                                                       3.89E-23           Aquaporin 12A
  Smp_125060        5.55                                                       6.70E-04           kinase suppressor of Ras (KSR)
  Smp_198060        5.51                                                       4.73E-13           hypothetical protein

\*Log~2~FC (lung/D13), logarithm of the fold change in expression level between lung stage and day-13 schistosomula

The GO term *cellular iron ion homeostasis* was enriched amongst genes up-regulated in lung stage compared to day-13 schistosomula ([S3 Table](#pntd.0007743.s010){ref-type="supplementary-material"}). For example, the *ferritin*-2 genes (Smp_047650, Smp_047660, Smp_047680; somal ferritin) displayed fold changes in the range 2.1--7.2 ([S2](#pntd.0007743.s009){ref-type="supplementary-material"} and [S3](#pntd.0007743.s010){ref-type="supplementary-material"} Tables). Although down-regulated in day-13 compared to lung stage schistosomula, these three *ferritin* genes were still expressed at a time when iron is required for growth and development ([S2 Fig](#pntd.0007743.s002){ref-type="supplementary-material"}). Another ferritin isoform, ferritin-1 (Smp_087760; yolk ferritin), is associated with vitelline cells \[[@pntd.0007743.ref051],[@pntd.0007743.ref052]\] and in the present study showed increasing expression as the parasite developed into adult stage ([S2 Fig](#pntd.0007743.s002){ref-type="supplementary-material"}). However, sex-biased expression of ferritin-1 and 2 has previously been reported \[[@pntd.0007743.ref051],[@pntd.0007743.ref052]\] and in our mixed-sex samples, we cannot rule out the possibility that our later collection time points contained a greater proportion of female worms. In contrast, other genes related to iron-sequestration were expressed at a similar level in the lung stage and day-13 stage, such as *putative ferric reductase* (Smp_136400) and *divalent metal transporter* (*DMT 1)* (Smp_099850) ([S3 Fig](#pntd.0007743.s003){ref-type="supplementary-material"}). Both genes are hypothesised to be involved in the same pathway, with the *putative ferric reductase* cleaving iron from host transferrin (glycoprotein iron carrier) before transporting into the parasite *via* a *DMT* \[[@pntd.0007743.ref053],[@pntd.0007743.ref054]\].

Micro-exon genes (MEGs), whose structures mainly comprise short exons with lengths that are multiples of three bases, are an abundant feature in parasitic helminths \[[@pntd.0007743.ref055],[@pntd.0007743.ref056]\]. Despite expression across all developmental stages, and at least 41 MEGs being annotated and assigned into sequence-similarity families \[[@pntd.0007743.ref055],[@pntd.0007743.ref057]\], little is known about their function. *MEG-14* has been shown to interact with an inflammatory-related human protein \[[@pntd.0007743.ref058]\], and *MEG-3*, *MEG-14*, *MEG-15*, *MEG-17 and MEG-32*, were previously identified in the oesophagus of schistosomula or adults \[[@pntd.0007743.ref059]\]. Multiple MEGs were up-regulated in the lung stage, e.g. 6 of the 72 genes in the major lung stage expression clusters (cluster 8, 24 and 32) were MEGs ([S8 Table](#pntd.0007743.s015){ref-type="supplementary-material"}). Most strikingly, cluster 8 contains eight genes, of which four are micro-exon genes (MEGs); two from the *MEG-2* family and two from *MEG-3* family ([S8 Table](#pntd.0007743.s015){ref-type="supplementary-material"}). Three of these MEGs (Smp_159810, Smp_138070, Smp_138080) were previously shown to be up-regulated in schistosomula, three days after *in vitro* transformation and detected in schistosomula or egg secretions \[[@pntd.0007743.ref057]\]. Furthermore, a pairwise comparison revealed a total of 17 MEGs, from seven families, that were up-regulated in lung stage compared to day-13 schistosomula ([S2 Table](#pntd.0007743.s009){ref-type="supplementary-material"}), with seven MEGs amongst the top 20 lung-stage up-regulated genes ([Table 1](#pntd.0007743.t001){ref-type="table"}). In contrast, only one MEG, a member of *MEG-32*, was up-regulated in day-13 schistosomula compared to the lung stage ([S2 Table](#pntd.0007743.s009){ref-type="supplementary-material"}).

Lung stage expressed genes with anti-inflammatory roles {#sec019}
-------------------------------------------------------

Genes involved in defence against oxidative stress were highly expressed in lung schistosomula, presumably to neutralise reactive oxygen species (ROS) produced during inflammation. For instance, expression of *extracellular superoxide dismutase* was 17-fold higher than in day-13 parasites (Smp_174810) ([S2 Table](#pntd.0007743.s009){ref-type="supplementary-material"} and [S4 Fig](#pntd.0007743.s004){ref-type="supplementary-material"}). Superoxide dismutase catalyses the detoxification of superoxide into hydrogen peroxide and molecular oxygen \[[@pntd.0007743.ref054],[@pntd.0007743.ref060]\]. The antioxidant *thioredoxin peroxidase* (Smp_059480) that neutralises peroxide \[[@pntd.0007743.ref061]\] was similarly up-regulated (more than 16-fold) in the lung stage ([S2 Table](#pntd.0007743.s009){ref-type="supplementary-material"}) and thioredoxin glutathione reductase (TGR; Smp_048430), another important redox enzyme \[[@pntd.0007743.ref062]\], showed marginally higher expression in the lung stage ([S5 Fig](#pntd.0007743.s005){ref-type="supplementary-material"}). The gene encoding *single Kunitz protease inhibitor* (Smp_147730, [S6 Fig](#pntd.0007743.s006){ref-type="supplementary-material"}), putatively involved in host immune defence \[[@pntd.0007743.ref063]\], was also highly expressed in the lung stage (16-fold greater than day 13, adjusted p-value \< 1E-100) ([S2 Table](#pntd.0007743.s009){ref-type="supplementary-material"}).

These three genes with particularly striking up-regulation in the lung stage belong to the same cluster (cluster 72). Given the possible roles of cluster 72 genes in counteracting oxidative stress and in host immune system evasion, other genes from this cluster were explored in more detail. Cluster 72 contained seven additional genes ([Table 2](#pntd.0007743.t002){ref-type="table"}). Three encoded hypothetical proteins of unknown function, while the other four were predicted, based on sequence similarity, to encode proteins with recognisable products. The first, *arginase* (Smp_059980), is hypothesised to counteract the host immune response by depleting L-arginine from blood, thereby preventing it from being used by macrophages in the production of nitric oxide \[[@pntd.0007743.ref064],[@pntd.0007743.ref065]\]. The second, a schistosome homologue of *early growth response protein* (EGR, Smp_134870) displayed zinc finger and DNA-binding domains suggesting a transcription factor role, although its targets are not known. The third and fourth proteins contained *PDZ* and *LIM* domains (Smp_156510, Smp_166920) but these also have no obvious link with host immune evasion.

10.1371/journal.pntd.0007743.t002

###### Genes in cluster 72.

![](pntd.0007743.t002){#pntd.0007743.t002g}

  Gene identifier   Product name
  ----------------- ------------------------------------------------------------------
  Smp_059480        thioredoxin peroxidase
  Smp_059980        arginase
  Smp_074570        hypothetical protein
  Smp_114660        hypothetical protein
  Smp_134870        early growth response protein
  Smp_147730        single Kunitz protease inhibitor; serine type protease inhibitor
  Smp_156510        PDZ and LIM domain protein 7
  Smp_166920        PDZ and LIM domain protein Zasp
  Smp_174810        Extracellular superoxide dismutase (Cu Zn)
  Smp_182770        hypothetical protein

Cluster 64 contained genes with similar expression profiles to cluster 72 and like the latter cluster, was annotated with GO terms enriched for redox processes ([S12 Table](#pntd.0007743.s019){ref-type="supplementary-material"}). Clusters 64 and 72 also contained genes involved in cellular metabolism and transport. However, enrichment for these specific GO terms became more pronounced when two additional clusters (71 and 80), with reduced lung stage expression ([Fig 4](#pntd.0007743.g004){ref-type="fig"} green boxes), were included in the analysis ([S13](#pntd.0007743.s020){ref-type="supplementary-material"} and [S14](#pntd.0007743.s021){ref-type="supplementary-material"} Tables). Amongst the top enriched GO terms for all four clusters was *carbohydrate transport* with two glucose transporters (Smp_012440 and Smp_105410) that have been previously characterised in *S*. *mansoni* \[[@pntd.0007743.ref042]\].

Hypothetical protein with predicted structure matching a complement cascade regulator {#sec020}
-------------------------------------------------------------------------------------

With four genes out of ten in cluster 72 potentially involved in host immune interactions, the three that encoded hypothetical proteins (Smp_074570, Smp_114660, Smp_182770) were investigated further. Peptides encoded by Smp_074570 are abundant (top 10) in secreted extracellular vesicles produced by *S*. *mansoni* schistosomula \[[@pntd.0007743.ref066]\], suggesting a role in host-parasite interactions. No further published information was found for products of the other two genes, and both contained no known signature domains. I-TASSER protein-structure prediction software \[[@pntd.0007743.ref033]--[@pntd.0007743.ref035]\] was therefore used to align predicted structures against known structures in the Protein Data Bank (PDB) \[[@pntd.0007743.ref036]\]. No match was found for Smp_074570 and Smp_114660 but, remarkably, Smp_182770 produced a single high confidence match (TM-score \> 0.9) to human complement factor H (CFH; PDB entry 3GAW) \[[@pntd.0007743.ref067]\] ([Fig 5](#pntd.0007743.g005){ref-type="fig"}).

![Predicted structure of Smp_182770 aligned with structure of human CFH.\
(A) Three-dimensional structure of Smp_182770 predicted using the I-TASSER server. (B) Alignment between the predicted structure (blue) and 3D structure of human CFH (red) in 250 mM NaCl buffer, obtained from PDB (entry 3GAW). (C) Domain components of human CFH identified from multiple databases using the InterProScan web server \[[@pntd.0007743.ref038]\]. SCR, short consensus repeat; CCP, complement control protein. Both SCR and CCP are alternative names of the *sushi* domain. CFH is a well-characterised regulator of the complement cascade that is found on the surface of human cells and prevents complement attack on self \[[@pntd.0007743.ref068],[@pntd.0007743.ref069]\]. The human CFH (PDB entry 3GAW) contains *sushi/ccp* domain repeats (Fig 5C) involved in regulating complement cascade. Smp_182770 does not contain the *sushi/ccp* domain repeats but it does encode tandem repeats similar to those expected from mammalian CFH genes \[[@pntd.0007743.ref070]\].](pntd.0007743.g005){#pntd.0007743.g005}

Homologues of the Smp_182770 are present in other *Schistosoma* species as well as other flatworms, such as the liver flukes *Fasciola*, *Opisthorchis*, and *Clonorchis*, and the intestinal fluke *Echinostoma* ([Fig 6A](#pntd.0007743.g006){ref-type="fig"}), suggesting an evolutionarily-conserved role \[[@pntd.0007743.ref071],[@pntd.0007743.ref072]\]. The Smp_182770 locus in *S*. *mansoni* genome is immediately adjacent to Smp_038730, another hypothetical protein. RNA-seq mapping suggested that the two were in fact parts of the same gene ([Fig 6B](#pntd.0007743.g006){ref-type="fig"}). From gene clustering, Smp_038730 is in cluster 24 which has a similar expression pattern to cluster 72, but with noticeably lower expression in the adult stage ([Fig 4](#pntd.0007743.g004){ref-type="fig"} yellow box and [S1 Fig](#pntd.0007743.s001){ref-type="supplementary-material"}). In a subsequent version of the *S*. *mansoni* genome (available from [parasite.wormbase.org](http://parasite.wormbase.org)), the two genes have been merged to become Smp_334090. The predicted structure of Smp_334090 also resembles that of human CFH (TM-score = 0.830) ([S7 Fig](#pntd.0007743.s007){ref-type="supplementary-material"}).

![Homologous relationship of Smp_182770 and alignment of RNA-seq reads to genomic locations.\
A) Homologues of Smp_182770. Information on homologues of genes was obtained from WormBase ParaSite, release 8 \[[@pntd.0007743.ref023]\], based on gene-trees generated by the Compara pipeline \[[@pntd.0007743.ref073]\]. Gene identifiers from WormBase ParaSite are shown in parentheses after the species names. B) Artemis screenshot showing the genomic region that contains Smp_182770 and RNA-seq reads mapped from multiple RNA-seq libraries (two top rows).](pntd.0007743.g006){#pntd.0007743.g006}

Discussion {#sec021}
==========

We have described a complete transcriptome time-course of *S*. *mansoni* covering key developmental stages during the intra-mammalian infection, including the first RNA-seq transcriptome of *in vivo* lung schistosomula. The data recapitulated known major biological changes for well-characterised parts of the life cycle in the mammalian host, as well as provided novel insights into molecular processes underlying parasite development and interactions with the host. In particular, analysis of the lung developmental stage highlighted striking signalling pathways, including those related to developmental control, cell differentiation and neuropeptide signalling. In addition, tentative strategies for immune evasion such as up-regulation of iron homeostasis, oxidative stress-related genes, and anti-inflammatory genes were revealed.

In early stages of *S*. *mansoni* infection, schistosomula elongate and migrate within lung capillaries \[[@pntd.0007743.ref074]\]. Although the cues involved in these changes are unknown \[[@pntd.0007743.ref075]\], it is believed that schistosomula differentiate or remodel their existing cells, rather than trigger cell division \[[@pntd.0007743.ref003],[@pntd.0007743.ref041]\]. The up-regulation of signalling-related genes in this developmental stage emphasises processes required for successful migration through lung capillaries. Furthermore, changes in development-related genes may play roles in the remodelling or trigger developmental onset observed in later stages. In some parasitic trematodes, fixed behavioural patterns have been associated with specific developmental stages involved in processes such as migration, site-finding, and adhesion \[[@pntd.0007743.ref076],[@pntd.0007743.ref077]\]. Given that the lung stage undergoes major morphological changes, an increase in neuronal activities indicated by our data may reflect distinct behaviours associated with the new phase of development, as well as responses to a new environment within the lung capillaries. Neuronal signalling is one of the processes disturbed in irradiated schistosomes \[[@pntd.0007743.ref078]\] many of which exit lung capillaries into the alveoli and eventually die during lung migration \[[@pntd.0007743.ref020],[@pntd.0007743.ref074],[@pntd.0007743.ref079]\]. The migration through the lung capillaries represents a challenge for the schistosomula. Moving within narrow lung capillaries, the schistosomula are in direct contact with the capillary endothelium \[[@pntd.0007743.ref074]\] and they may interrupt blood flow, increasing the risk of microthrombosis or leading to an accumulation of circulating immune cells \[[@pntd.0007743.ref080]\]. However, it has been shown that lung schistosomula can resist direct cytotoxic immune killing \[[@pntd.0007743.ref019],[@pntd.0007743.ref079],[@pntd.0007743.ref081],[@pntd.0007743.ref082]\]. Lung inflammation is observed during the infection, but it appears not to be associated with the location of migrating parasites, but instead triggered by damaged host tissue \[[@pntd.0007743.ref083]\]. The accumulation of immune cells, instead of killing the parasites, is thought to either disrupt blood vessels, inducing microhemorrhage and causing the parasites to migrate into the alveoli, or it may act as a plug that blocks migration \[[@pntd.0007743.ref020],[@pntd.0007743.ref084]\].

Our data revealed that multiple genes with potential immune evasion or protective roles are up-regulated. One example was the *Kunitz protease inhibitor* that has an anti-coagulation and anti-inflammation role \[[@pntd.0007743.ref063]\] and has been proposed as a vaccine candidate against *S*. *mansoni* \[[@pntd.0007743.ref085]\]. Neutralisation of oxidative stress by up-regulating dismutase and peroxidase systems may mitigate the effects of inflammation caused by migrating schistosomula. Both reactive oxygen species (ROS) and iron metabolism are involved in the host immune response; therefore, iron homeostasis and ROS neutralisation have likely evolved as an immune evasion strategy in these parasites \[[@pntd.0007743.ref054]\]. Schistosomula also clearly face the risk of oxidative damage from the uniquely high oxygen tension in the lung \[[@pntd.0007743.ref086],[@pntd.0007743.ref087]\] and therefore have a further requirement for maintaining redox balance. In rodents, expression of thioredoxin is induced by oxidative stress \[[@pntd.0007743.ref087]\]. The up-regulation of schistosome ROS metabolism likely also depends on changes in the environment rather than a hard-wired gene expression programme. In contrast to our *in vivo* results from lung schistosomula, genes related to stress and immune evasion are expressed at a lower level when the parasites are cultivated *in vitro* \[[@pntd.0007743.ref008]\], highlighting the need to study parasites obtained from their most natural environment to understand relevant biological processes.

Multiple genes with tentative roles in immune evasion displayed particularly high expression in the lung stage, moderately high expression in adult stages and lower expression in the liver stages. In particular, a previously uncharacterised gene, annotated as a hypothetical protein, with this expression pattern was predicted to be structurally similar to the human complement factor H (CFH), a regulator of the complement cascade. In mammals, CFH cleaves C3b, a central protein in the complement cascade \[[@pntd.0007743.ref088]\]. The regulatory function of CFH involves two other molecules---its cofactor complement factor I (CFI) \[[@pntd.0007743.ref069]\] and decay-accelerating factor (DAF) \[[@pntd.0007743.ref068]\]. To date, a *S*. *mansoni* gene with sequence or structural similarity to CFI has not been described, but the parasites do possess a serine protease, m28, that cleaves C3bi (a function normally carried out by CFI \[[@pntd.0007743.ref068],[@pntd.0007743.ref089]\]). For DAF, a native *S*. *mansoni* form has not been reported but schistosomes can acquire DAF from host blood cells \[[@pntd.0007743.ref090],[@pntd.0007743.ref091]\]. Given the nature of other genes sharing its expression pattern, the structural match to human CFH, and its phylogenetic relationship, it is tempting to speculate that the CFH-like gene in schistosomes may have a role in immunomodulation. Nevertheless, host immune system proteins have been shown to interact with schistosomes in their developmental signalling pathways \[[@pntd.0007743.ref092]\]. CFH in mammals not only cleaves C3b, but also has been implicated in lymphocyte extracellular secretion and DNA synthesis \[[@pntd.0007743.ref092]\]. In addition, schistosomes have a 130 kDa surface protein that can bind to C3, inactivating the C3 complement-activation, and the binding stimulates renewal of the parasite surface membrane \[[@pntd.0007743.ref088],[@pntd.0007743.ref093]\]. To have another, CFH-like protein identified here, inhibiting the downstream product of C3 activation, may seem redundant. However, its potential roles in immunomodulation should not be ruled out. It is common for pathways to have regulators at various steps, particularly for C3 which is focal for complement cascade activation and is involved in clearing *S*. *mansoni* after praziquantel administration \[[@pntd.0007743.ref088],[@pntd.0007743.ref094]\].

Certain limitations need to be borne in mind when interpreting the data from this study. First, it has been shown that gene expression can change with the types of hosts \[[@pntd.0007743.ref095],[@pntd.0007743.ref096]\] and, therefore, this limits extrapolation of findings from mouse host to humans. In *S*. *japonicum*, microarray data of adult worms collected from two different mouse strains, rabbits and water buffaloes (natural host) displayed highly correlated expression profiles across different host types. Nevertheless, over 400 genes were identified as differentially expressed, particularly including those likely to be involved in signal transduction and metabolism \[[@pntd.0007743.ref095]\]. Second, our transcriptome data were produced by 'bulk' RNA-seq from pooled mixed-sex worms. In bulk RNA-seq, strong signals from rarer cells types can be averaged out, and gene expression changes can therefore be missed if, for instance, a gene is up-regulated in one cell type but down-regulated in another. Single-cell transcriptomic analyses promise to overcome this limitation \[[@pntd.0007743.ref097]\]. Using mixed-sex worms in our study was another possible confounder for genes, such as ferritin-1, where there is differential expression between male and female worms. However, the majority of our analyses focused on earlier stages where the sexes show little or no differentiation. Despite these various caveats that are common to many bulk analyses, the good agreement with key known events during parasite development provides confidence that the major transcriptional signatures we have detected reflect major changes within the parasite.

The data produced from this study will serve as a unique resource for the research community to explore changes across intra-mammalian stages of schistosome development. Our particular focus on the lung stage demonstrated consistency with previous observations and introduced potential new players in host-parasite interactions and parasite development. Further investigation and functional validation of genes identified here will help to decipher mechanisms for parasite long-term survival within the mammalian host, exposing vulnerabilities that can be exploited to develop new control strategies for this neglected tropical pathogen.

Supporting information {#sec022}
======================

###### Clusters of genes based on timecourse expression pattern, with fixed y-axes.

Expression profile of genes differentially expressed in at least one time point clustered into 96 groups. The clustering was done on mean-normalised regularized log transformation (rlog- transformed) of raw read counts. X-axes represent six time points from this dataset; y-axes represent the mean-normalised rlog-transformed. Unlike [Fig 4](#pntd.0007743.g004){ref-type="fig"}, this supplementary figure shows clusters with a fixed range for the y-axis across all clusters in order to visualise clusters with the largest changes over time.

(TIF)

###### 

Click here for additional data file.

###### Expression of genes encoding ferritin-heavy chain over the timecourse.

Each dot represents one replicate from each of the time points. Y-axis represents normalised counts from DESeq2.

(TIF)

###### 

Click here for additional data file.

###### Expression of genes encoding putative ferric reductase (cytochrome b 561; Smp_136400) and Divalent Metal Transporter (DMT1) (Smp_099850) over the timecourse.

Each dot represents one replicate from each of the time points. Y-axis represents normalised counts from DESeq2.

(TIF)

###### 

Click here for additional data file.

###### Expression of genes encoding two extracellular superoxide dismutases (Smp_174810 and Smp_095980) over the timecourse.

Expression of Smp_174810 and Smp_095980 with y axes on log scale. Each dot represents one replicate from each of the time points. Y-axis represents normalised counts from DESeq2. Smp_095980 was identified as differentially expressed ([S2 Table](#pntd.0007743.s009){ref-type="supplementary-material"} and [S4 Fig](#pntd.0007743.s004){ref-type="supplementary-material"}), but this figure shows that its expression in the lung stage was high in only one out of seven replicates.

(TIF)

###### 

Click here for additional data file.

###### Expression of genes encoding thioredoxin glutathione reductase over the timecourse.

Each dot represents one replicate from each of the time points. Y-axis represents normalised counts from DESeq2. Log~2~FC between D13/D06 is -0.52, adjusted p-value for differential expression between D13/D06 is 4.10e-21.

(TIF)

###### 

Click here for additional data file.

###### Expression of genes encoding single Kunitz serine protease inhibitor over the timecourse.

Each dot represents one replicate from each of the time points. Y-axis represents normalised counts from DESeq2.

(TIF)

###### 

Click here for additional data file.

###### Predicted structure of Smp_334090 aligned with structure of human CFH.

A\) Predicted 3D structure of Smp_334090 (resulting from a merge of Smp_182770 and Smp_038730 in the most recent version of the *S*. *mansoni* genome) by I-TASSER based on the amino acid sequence. B) Alignment between the predicted structure (blue) and 3D structure of human CFH (in 137 mM NaCl buffer) obtained from PDB (PDB identifier: 3GAV) (red).

(TIF)

###### 

Click here for additional data file.

###### Genes that were differentially expressed in at least one time point (likelihood ratio test, adjusted p-value \< 0.01).

(XLSX)

###### 

Click here for additional data file.

###### Differentially expressed genes between day-13 and lung stage *S*. *mansoni*.

(XLSX)

###### 

Click here for additional data file.

###### Enriched GO terms of genes differentially expressed between day-13 and lung stage *S*. *mansoni*.

(XLSX)

###### 

Click here for additional data file.

###### Differentially expressed genes between day-28 and day-21 *S*. *mansoni*.

(XLSX)

###### 

Click here for additional data file.

###### Enriched GO terms of genes differentially expressed between day-28 and day-21 *S*. *mansoni*.

(XLSX)

###### 

Click here for additional data file.

###### Differentially expressed genes between day-35 and day-28 *S*. *mansoni*.

(XLSX)

###### 

Click here for additional data file.

###### Enriched GO terms of genes differentially expressed between day-35 and day-28 *S*. *mansoni*.

(XLSX)

###### 

Click here for additional data file.

###### Genes differentially expressed in at least one time point identified by their clustered expression profiles.

(XLSX)

###### 

Click here for additional data file.

###### GO term enrichment of genes with high expression during liver stages (genes in cluster 1, 2, 9, 10, 17, 25, 26, 27, 33, 34).

(XLSX)

###### 

Click here for additional data file.

###### GO enrichment of genes up-regulated in lung stage (genes in cluster 8, 24, 32).

(XLSX)

###### 

Click here for additional data file.

###### Enriched GO terms of genes with high expression in lung stage followed by a steady decline toward adult (genes in cluster 5, 6, 7, 13, 14, 15, 16, 21, 22, 23, 31).

(XLSX)

###### 

Click here for additional data file.

###### Enriched GO terms of genes with high expression in lung stage, low expression in liver stages, and increased expression in adult stages (genes in cluster 64, 72).

(XLSX)

###### 

Click here for additional data file.

###### Enriched GO terms of genes with high expression in lung stage, low expression in liver stages, and increased expression in adult stages (genes in cluster 71, 80).

(XLSX)

###### 

Click here for additional data file.

###### Enriched GO terms of genes with high expression in lung stage, low expression in liver stages, and increased expression in adult stages (genes in cluster 64, 71, 72, 80).

(XLSX)

###### 

Click here for additional data file.

###### RNA-seq details.

Total number of reads and % mapped to *S*. *mansoni* genome for each sample.

(DOCX)

###### 

Click here for additional data file.

###### Genome annnotation file.

GFF file containing annotation for *S*. *mansoni* longest transcript. The file was used for generating read counts from HTSeq-count.

(GFF)

###### 

Click here for additional data file.

###### Final counts.

A zipped folder containing final counts from HTSeq-count. The folder contains the following files: D06_SM_1\_17675_4\_1.htseq-count.txt, D06_SM_2\_17675_4\_2.htseq-count.txt, D06_SM_3\_17675_4\_3.htseq-count.txt, D06_SM_4\_17675_4\_4.htseq-count.txt, D06_SM_5\_17675_4\_5.htseq-count.txt, D06_SM_6\_17675_4\_6.htseq-count.txt, D06_SM_7\_17675_4\_7.htseq-count.txt, D13_SM_1\_17675_4\_8.htseq-count.txt, D13_SM_2\_17675_4\_9.htseq-count.txt, D13_SM_3\_17675_4\_10.htseq-count.txt, D17_SM_1\_17675_4\_11.htseq-count.txt, D17_SM_2\_17675_4\_12.htseq-count.txt, D17_SM_3\_17675_4\_13.htseq-count.txt, D21_SM_1\_17675_4\_14.htseq-count.txt, D21_SM_2\_17675_4\_15.htseq-count.txt, D21_SM_3\_17675_4\_16.htseq-count.txt, D28_SM_1\_17675_4\_17.htseq-count.txt, D28_SM_2\_17675_4\_18.htseq-count.txt, D28_SM_3\_17675_4\_19.htseq-count.txt, D35_SM_1\_17675_4\_20.htseq-count.txt, D35_SM_2\_17675_4\_21.htseq-count.txt, D35_SM_3\_17675_4\_22.htseq-count.txt.

(ZIP)

###### 

Click here for additional data file.
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Dear Dr Berriman:

Thank you very much for submitting your manuscript \"Transcriptome of the parasitic flatworm Schistosoma mansoni during intra-mammalian development\" (PNTD-D-19-01474) for review by PLOS Neglected Tropical Diseases. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified a few aspects of the manuscript that should be improved.

We therefore ask you to modify the manuscript according to the review recommendations before we can consider your manuscript for acceptance. Your revisions should address the specific points made by each reviewer.

In addition, when you are ready to resubmit, please be prepared to provide the following:

\(1\) A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

\(2\) Two versions of the manuscript: one with either highlights or tracked changes denoting where the text has been changed (uploaded as a \"Revised Article with Changes Highlighted\" file ); the other a clean version (uploaded as the article file).

\(3\) If available, a striking still image (a new image if one is available or an existing one from within your manuscript). If your manuscript is accepted for publication, this image may be featured on our website. Images should ideally be high resolution, eye-catching, single panel images; where one is available, please use \'add file\' at the time of resubmission and select \'striking image\' as the file type.

Please provide a short caption, including credits, uploaded as a separate \"Other\" file. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License at <http://journals.plos.org/plosntds/s/content-license> (NOTE: we cannot publish copyrighted images).

\(4\) Appropriate Figure Files

Please remove all name and figure \# text from your figure files upon submitting your revision. Please also take this time to check that your figures are of high resolution, which will improve both the editorial review process and help expedite your manuscript\'s publication should it be accepted. Please note that figures must have been originally created at 300dpi or higher. Do not manually increase the resolution of your files. For instructions on how to properly obtain high quality images, please review our Figure Guidelines, with examples at: <http://journals.plos.org/plosntds/s/figures>

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/> PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We hope to receive your revised manuscript by November 24, 2019. If you anticipate any delay in its return, we ask that you let us know the expected resubmission date by replying to this email.

To submit your revised files, please log in to <https://www.editorialmanager.com/pntd/>

If you have any questions or concerns while you make these revisions, please let us know.

Sincerely,

Matty Knight, Ph.D

Associate Editor

PLOS Neglected Tropical Diseases

Walderez Dutra

Deputy Editor

PLOS Neglected Tropical Diseases

\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Reviewer\'s Responses to Questions

**Key Review Criteria Required for Acceptance?**

As you describe the new analyses required for acceptance, please consider the following:

**Methods**

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer \#1: See below

Reviewer \#2: The objectives of the study are clear and study design is appropriate as presented, but I am concerned that previous knowledge from studies of additional life cycle stages are not discussed.

The sample size is adequate and there are no ethical concerns.

Reviewer \#3: The authors' submitted manuscript "Transcriptome of the parasitic flatworm Schistosoma mansoni during intra-mammalian development" investigated the temporal changes in the gene expression of S. mansoni in mice. This work has highlighted gaps in current understanding of S. mansoni infection and has provided valuable data adding to the current knowledge of the possible molecular mediators during host-parasite infection by studying gene expression of six developmental stages of the parasite. The authors used RNA-seq to analyze the transcriptomic profiles of the parasites and used bioinformatics tools to further analyze the biological significance of the gene expression. The authors have also done a thorough analysis and speculating signaling pathways that might be involved during the infection based on the expression profiles of genes showing differential expression at different developmental stages by performing cluster and GO term analysis. The authors further investigated the three hypothetical proteins that are involved in host immune interactions by protein structure prediction. Based on differential expression analysis the authors found micro-exon-genes (MEGs) to be highly up-regulated in day 6 as compared to day-16 schistosomula recapitulated some of the data shown in previous studies. In addition, data from the manuscript showed that the major signaling pathways regulated during these six developmental stages are those related to developmental control, cell differentiation and host interaction (including oxidative stress, iron homeostasis and inflammation) and found that one of the proteins aligned with the structure of human CFH, a regulator of the complement cascade. Overall this manuscript is clearly written and easy to follow. Methods used to generate the transcriptome data were also well presented.

Minor comments:

1\. (Line 77) Previous studies on intra-mammalian development of S. mansoni were mentioned and it would have been helpful for the general audience to include statements on the major findings/summaries from those in vitro/in vivo studies.

2\. Authors should include details of the raw RNA-seq data including number of reads obtained and % of mapping.

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Results**

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer \#1: See below

Reviewer \#2: The analyses presented match the study plan and the results are clearly and completely described and the figures are clear.

Reviewer \#3: see above

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Conclusions**

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer \#1: See below

Reviewer \#2: The conclusions are supported but the limitations could be better addressed. The authors clearly describe how the results can advance the field.

Reviewer \#3: see above

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Editorial and Data Presentation Modifications?**

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend "Minor Revision" or "Accept".

Reviewer \#1: See below

Reviewer \#2: None

Reviewer \#3: see above

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

**Summary and General Comments**

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer \#1: Although the paper and approach are not entirely novel, the work presented herein presents a new and authoritative understanding of gene expression during development of Schistosome mansoni in its experimental host. The work uncovers the profiles of molecules involved in a range of activities at the host-parasite interface. The separation of lung-phase worms appears to be quite rapid compared with those of previous studies and there is some confidence that the transcriptome(s) of this stages approaches the native state.

The manuscript is clear and well presented and will make a fine contribution. Some minor comments are made below to assist improve an already strong manuscript.

1\. Line 262. Upregulation of molecules associated with neuronal function. One very interesting analysis of Fasciola development in its mammal host by MV Sukhdeo of Rutgers University suggested that trematodes followed fixed actions patterns of behaviour, that is, the parasites displayed certain behaviours that facilitated their development to a certain point. Having reached that point, a whole new set of behaviours were initiated. The lung stage of Schistosoma seems critical in development and host-parasite interaction and some major morphological changes occur in the parasites in the time they are present in the lungs. So, just as a thought exercise, I wonder if it is worthwhile adding that the neuronal activity is also associated with a transition to a whole new phase of development?

2\. I was happy to see reference to iron metabolism and the putative iron transporters and related genes. The findings of ferritin are interesting. Work on S mansoni (Schüssler et al Mol Reprod Dev. 1995 Jul;41(3):325-30) and S japonicum (Jones 2007;39(9):1646-58) demonstrate that one form of ferritin (called yolk ferritin) is associated with vitelline cells. Iron was proposed to be either stored in vitelline cells as part of the requirements for development in the snail (Schüssler) or to stabilise the egg shells (Jones). One would expect or hope to see one ferritin shoot up in its transcriptomic profiles in older worms. Is there any evidence of this occurring. Given the statement above, does the drop in ferritin levels at day 13 seem somewhat strange?

3\. I may have missed it, but do the authors have a way of determining the numbers of males and females in each host at different stage? Is the gender balance the same in all mice? Implicit in this question is the concept that males and females will, or be expected to, have distinct transcriptional profiles at all stages. Would a difference in gender balance between mice or between stages skew the transcriptomes? Thus, is there a way of, using either male-only or female-only genes as markers of the numbers of respective gender balance?

Reviewer \#2: The research presented here in the manuscript of Wangwiwatsin et al, is experimentally sound and examines difficult to study in vivo lifecycle stages with the power of and quantitative advantages of RNA-seq. Of the work that is presented I have almost no concerns and several interesting findings, especially the CHF and other immune-related findings. My concerns and request for major revision are focused on what is not presented. In particular:

1\) The source of the S. mansoni parasites used is not presented.

2\) There is no discussion of potential parasite gene expression differences in a mouse vs human host.

3\) The references to previous RNA-seq analysis of Schistosoma gene expression including S. mansoni is quite lacking, only much older literature is cited. In fact, this manuscript fails to cite a previous Berriman bioRxiv analysis of existing RNA-seq data doi: <https://doi.org/10.1101/308189>

4\) Despite the fact that the S. mansoni genome is now on version 8, with version 7 publicly released by the Wellcome Trust for more than a year in WormBase Parasite, the much older assembly version 5 was sued. This seems odd. In fact, the MS has to go to this newer version to highlight a gene of interest that is mis-assembled in version 5.

4\) Most significantly, this manuscript only focuses on the data they have generated and fail to include gene expression insights from the rest the lifecycle. It is impossible to declare, as in line 321 \"Lung-stage specific\" when all stages are not considered. Given that the RNA-seq data for other stages exists and findings from these studies and microarrays exist these new data should be analyzed in that context.

5\) Minor comment line 379 \"appeared to upregulated\" what is the uncertainty?

Reviewer \#3: (No Response)

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosntds/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

Reviewer \#3: No
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27 Feb 2020

Dear Dr. Berriman,

We are pleased to inform you that your manuscript \'Transcriptome of the parasitic flatworm Schistosoma mansoni during intra-mammalian development\' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch within two working days with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution\'s press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Matty Knight, Ph.D

Associate Editor

PLOS Neglected Tropical Diseases

Walderez Dutra

Deputy Editor

PLOS Neglected Tropical Diseases

\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
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This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

24 Apr 2020

Dear Dr. Berriman,

We are delighted to inform you that your manuscript, \"Transcriptome of the parasitic flatworm Schistosoma mansoni during intra-mammalian development,\" has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc\...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article\'s publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Serap Aksoy

Editor-in-Chief

PLOS Neglected Tropical Diseases

Shaden Kamhawi

Editor-in-Chief

PLOS Neglected Tropical Diseases
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